View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
July 22, 2022

ArchiMed acquires neurodiagnostic devices provider Natus Medical

Natus shareholders received $33.50 in cash for each share of company common stock.

ArchiMed has completed the acquisition of US-based neurodiagnostic devices provider Natus Medical for nearly $1.2bn.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

The deal, first announced in April, represents the first purchase for the MED Platform II from ArchiMed , an investment firm that focuses on the healthcare industry.

As earlier agreed, Natus shareholders received $33.50 in cash for each share they held in the company.

ArchiMed Partner Justin Bateman said: “Together with management, we’ll significantly expand the reach and breadth of Natus’ market leading products, reinforce and focus research and development, and pursue acquisitions of complementary businesses.”

Headquartered in Middleton, Wisconsin, Natus focuses on delivering medical devices to support the screening, diagnosis and treatment of disorders that affect the brain, nervous and sensory systems.

The company provides 25 product lines globally.

Commenting on the transaction, Natus CEO Thomas J Sullivan said: “ArchiMed ’s mix of operational, medical, scientific and financial expertise will help us continue our mission to serve our customers as we further integrate, internationalise and grow our business.”

Natus will now become a private company with its shares delisted from private markets.

The Wisconsin-based company has also named current chief commercial officer Austin F Noll III as its new president.

Sullivan stated: “Austin’s leadership at Natus has been vital to our advancement as a leading Neuroscience company and I am pleased to partner with him in this next phase of our growth.”

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network